Praise for the First Edition aAs everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with informationabby the time the book is [published]abit is outdated.a [Tumor Board Review] is fresh and just out of the ovenabI havenat seen any book in oncology like this so farabI think my investment in this book was wise and worth it.a a Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists a both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several atumor board stylea illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process. NEW TO THE SECOND EDITION OF TUMOR BOARD REVIEW: Presents the most recent guidelines and management standards in user-friendly format Focuses on current indications, use of new drugs, and new treatment of side effects Includes new FDA-approved drugs and guidelines Offers approximately 250 multiple-choice questions and answersThe research on hormone-sensitive disease has focused on investigating optimal and more effective ways to use the ... Based on the recently published results from SWOG 9346, continuous ADT remains standard, and patients willing toanbsp;...
|Title||:||Tumor Board Review, Second Edition|
|Author||:||Kathleen A. Cooney, MD, Teresa G. Hayes, MD, PhD, Martha Pritchett Mims, MD, PhD, Robert F. Todd III, MD, PhD, Francis P. Worden, MD|
|Publisher||:||Demos Medical Publishing - 2015-02-12|